Biomanufacturing
-
A $3M NSF grant to advance biomanufacturing could help establish an innovative method to deliver medicines to cells
A team of Vanderbilt engineers, biologists and education specialists have received a $3 million grant from the National Science Foundation to advance large-scale biomanufacturing of cell-derived nanoparticles that can deliver precisely targeted drugs to the site of a disease. “Biomanufacturing is a growing but critical field that is reshaping how… Read MoreSep. 29, 2023
-
NSF seed grant supports biomanufacturing of new drug delivery technologies
Vanderbilt researchers awarded one of NSF’s 24 new projects to drive future manufacturing One of the challenges of drug delivery systems is to optimize their targeting properties so therapeutic compounds used in smaller amounts reach only a specific area of the body and result in little or no… Read MoreOct. 2, 2020